Insider Transactions in Q1 2024 at Insmed Inc (INSM)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2024
|
Melvin Md Sharoky Director |
BUY
Bona fide gift
|
Indirect |
3,600
+23.6%
|
-
|
|
Feb 28
2024
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Direct |
3,600
-1.21%
|
-
|
|
Feb 28
2024
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
50,000
+49.75%
|
$600,000
$12.58 P/Share
|
|
Jan 12
2024
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,251
-3.41%
|
$147,028
$28.63 P/Share
|
|
Jan 12
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,667
-4.18%
|
$130,676
$28.63 P/Share
|
|
Jan 10
2024
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,536
-2.25%
|
$99,008
$28.9 P/Share
|
|
Jan 10
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,245
-1.1%
|
$34,860
$28.9 P/Share
|
|
Jan 09
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
3,668
-1.74%
|
$106,372
$29.15 P/Share
|
|
Jan 09
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
503
+0.47%
|
$10,060
$20.49 P/Share
|
|
Jan 09
2024
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,373
-2.67%
|
$66,444
$28.76 P/Share
|
|
Jan 09
2024
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,861
-1.61%
|
$52,108
$28.78 P/Share
|
|
Jan 09
2024
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,837
-2.38%
|
$111,273
$29.25 P/Share
|
|
Jan 09
2024
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,497
-3.79%
|
$130,413
$29.18 P/Share
|
|
Jan 09
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,715
-4.01%
|
$136,735
$29.01 P/Share
|
|
Jan 09
2024
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
9,887
-2.65%
|
$276,836
$28.72 P/Share
|
|
Jan 08
2024
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
45,120
-5.69%
|
$1,308,480
$29.5 P/Share
|
|
Jan 08
2024
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
45,120
+5.38%
|
$902,400
$20.49 P/Share
|
|
Jan 05
2024
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
6,979
-1.83%
|
$202,391
$29.26 P/Share
|
|
Jan 05
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,457
-1.37%
|
$42,253
$29.28 P/Share
|
|
Jan 05
2024
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
627
-0.7%
|
$18,183
$29.3 P/Share
|
|
Jan 05
2024
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,167
-1.0%
|
$33,843
$29.32 P/Share
|
|
Jan 05
2024
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,042
-1.85%
|
$88,218
$29.21 P/Share
|
|
Jan 05
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,386
-1.17%
|
$40,194
$29.2 P/Share
|
|
Jan 04
2024
|
William Lewis Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
37,869
+9.05%
|
-
|
|
Jan 04
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,800
+9.97%
|
-
|
|
Jan 04
2024
|
Michael Alexander Smith Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,800
+11.66%
|
-
|
|
Jan 04
2024
|
John Drayton Wise Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,873
+9.92%
|
-
|
|
Jan 04
2024
|
Roger Adsett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,873
+7.27%
|
-
|
|
Jan 04
2024
|
Sara Bonstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,873
+9.8%
|
-
|
|
Jan 04
2024
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,873
+9.77%
|
-
|
|
Jan 03
2024
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
20,071
-16.18%
|
$582,059
$29.19 P/Share
|
|
Jan 03
2024
|
John Drayton Wise Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,071
+13.93%
|
$381,349
$19.11 P/Share
|